Serving 500+ biopharmaceutical companies globally:
Generated: August 16, 2017
Which patents cover M.v.i.-12, and when can generic versions of M.v.i.-12 launch?M.v.i.-12 is a drug marketed by Hospira and Teligent Pharma Inc and is included in two NDAs.
|Suppliers / Packagers: see list||1|
|Bulk Api Vendors: see list||75|